Charlotte V. Cox

Newcastle Upon Tyne, ENG NE24HH, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Key features of the environment promoting liver cancer in the absence of cirrhosis.

Key features of the environment promoting liver cancer in the absence of cirrhosis.

Journal: Scientific reports
Published: May 09, 2021

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy.

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy.

Journal: Blood advances
Published: October 05, 2020

Investigating the response of paediatric leukaemia-propagating cells to BCL-2 inhibitors.

Investigating the response of paediatric leukaemia-propagating cells to BCL-2 inhibitors.

Journal: British journal of haematology
Published: January 23, 2020

Dual targeting of Hsp90 in childhood acute lymphoblastic leukaemia.

Dual targeting of Hsp90 in childhood acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: August 10, 2016

Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.

Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.

Journal: PloS one
Published: June 24, 2016

Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4.

Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4.

Journal: Stem cells (Dayton, Ohio)
Published: May 01, 2015

Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia.

Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia.

Journal: Blood
Published: April 05, 2014

Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.

Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.

Journal: Blood
Published: December 25, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026